3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor
Conditions
Endometrial Neoplasms
6
Neoplasms
5
Colonic Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Uterine Cervical Neoplasms
2
Neoplasm Metastasis
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Turcot syndrome
1
Triple Negative Breast Neoplasms
1
Sarcoma
1
Recurrence
1
Rectal Neoplasms
1
Rectal Adenocarcinoma with Mismatch-repair Deficient (dMMR)/ Microsatellite Instability-high (MSI-H)
1
Penile Neoplasms
1
Pathologic Complete Response
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Ovarian Carcinosarcoma
1
Neoplasms, Second Primary
1
Locally Advanced Rectal Cancer (LARC)
1
Hemangiosarcoma
1
Head and Neck Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Neuroendocrine
1
Carcinoma
1
Breast Neoplasms
1
Brain Neoplasms
1
Adrenocortical Carcinoma
1
Interventions
Magnetic Resonance Spectroscopy
12
Specimen Handling
10
Cisplatin
7
Radiation
6
pembrolizumab
5
Platinum
5
Biopsy
5
1,2-diaminocyclohexaneplatinum II citrate
5
Sentinel Lymph Node Biopsy
4
Drug Therapy
4
cemiplimab
3
X-Rays
3
Ultrasonography
3
Standard of Care
3
Radiotherapy, Intensity-Modulated
3
Radiotherapy
3
Cetuximab
3
Carboplatin
3
Taxes
2
Surgical Procedures, Operative
2
Practice Guidelines as Topic
2
Photons
2
Paclitaxel
2
Interviews as Topic
2
trastuzumab deruxtecan
1
toripalimab
1
technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran
1
sacituzumab govitecan
1
merphos
1
ipatasertib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Recruiting
×
Mouth Neoplasms
×
dostarlimab
×
Clear all
No trials found.